ResearcherLiaoning Cancer Hospital & InstituteActive in the last 2 years
Xin Liu
Matched on ORCID iD 0000-0002-5795-2948; OpenAlex author ID A5100352247. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Muscle strength and mass as predictors of pancreatic cancer: insights from the UK biobank. Co-author DOI 10.1186/s12885-025-14766-w↗
- MicroRNA-494 regulates Gli3 expression and inhibits pancreatic cancer cells growth and migration. Co-author DOI 10.1002/jcb.26658↗
- MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer. Co-author DOI 10.3892/ol.2018.9513↗
- EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway. First author DOI 10.1016/j.canlet.2016.06.021↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qian Yu · 1 shared paper, 2025 · strength 0.27
- Xiao Hu · 1 shared paper, 2025 · strength 0.27
- Yongbiao Ma · 1 shared paper, 2018 · strength 0.11
- Baomin Shi · 1 shared paper, 2018 · strength 0.11
- Hansi Li · 1 shared paper, 2018 · strength 0.07
- Xiaodong Tan · 1 shared paper, 2018 · strength 0.07
- Yifan Yang · 1 shared paper, 2018 · strength 0.07
- Yunhao Wu · 1 shared paper, 2018 · strength 0.07
- Xiaoyu Yin · 1 shared paper, 2016 · strength 0.06
- Shi‐Jing Mo · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.